Kaspar Bachmann
banner
kasparbachmann.bsky.social
Kaspar Bachmann
@kasparbachmann.bsky.social
MD | ICU Physician & Researcher
Passionate about gastrointestinal dysfunction, nutrition as well as ECMO and cardiopulmonary physiology. Enthusiast in #MatLab, signal analysis and data-driven research: https://pubmed.ncbi.nlm.nih.gov/?term=Kaspar+bachman
Problem is twofold: LoA are around +/- 10%. ScvO2 of 55 then is not helpful. Trends do not point in the same direction. We showed this here: pubmed.ncbi.nlm.nih.gov/36511508/

And other studies:

doi.org/10.1007/s00134…

doi.org/10.1053/j.jvca�
��

Bottom line: when it counts, it is not helpful.
April 8, 2026 at 7:47 PM
IAP measurement does not require seadtion or neuromuscular blockade. That is a myth that needs to disappear. Measuring pressure is simple and accurate; a measurement of 18 is what it is. Sedation and paralytics can lower that number, but that is a therapy for IAP rather than enabling a measurement.
April 8, 2026 at 7:37 PM
My issue with ScvO2 is, that it can be high while true mixed venous (SvO2) is low. It is a bad surrogate for SvO2.
So when in doubt, float a PAC and know for sure.
March 7, 2026 at 12:52 PM
My question is, does it truly matter? If there’s a strong signal, shouldn’t I be able to detect it using either method (and vice versa)? And if the signal is borderline, shouldn’t I arrive at the same interpretation if my application and understanding of the statistics used are accurate?
August 15, 2025 at 11:10 AM
Reposted by Kaspar Bachmann
@gurujosh.bsky.social presents the results of the MSSA domain of the SNAP 🫰 trial at #ESCMID2025

fluclox caused more acute kidney injury than cefazolin; early mortality favored cefazolin

Absolutely Herculean effort by the entire global trial team and practice changing data #teamcefazolin
April 12, 2025 at 3:00 PM
I don’t think that offering specific therapies out of the context of goals of care is helpful and may negatively impact the discussion and patient trajectory.
January 25, 2025 at 10:13 PM
I think we want to define where a patient wants to be in 1/3/6/12 months and with what level of quality of life. We as a team can then offer specific therapies (i.e. Trach/PEG but also other options such as mech. assist devices), if and only if these therapies align with the defined goals of care.
January 25, 2025 at 10:13 PM
Recently listened to this:

soundphysicians.com/podcast-epis...

Has some good pearls and pitfalls and some resources in the shownotes.
soundphysicians.com
January 1, 2025 at 7:06 AM
📌
December 23, 2024 at 8:25 PM
Do you/does anyone know if there are data repositories with patient data, timepoints and vanco levels as well as reference clearence (maybe from observational studies)?
We could then use that to 1) validate and 2) develop new models.
December 19, 2024 at 8:28 AM
#emimcc
I plan to do a thread on the paper/topic soon. This project has kept me busy over the last two years and it has been a pleasure working alongside an awesome steering committee and Delphi panel. 🙏
December 18, 2024 at 4:58 PM